GB:0W8U Stock Latest News
Company AnnouncementsNeovacs Co-Organizes Pioneering French Meeting on Lipid Nanoparticles for RNA Delivery1y ago
Company AnnouncementsNeovacs Optimizes Financing Strategy with Trust Agreement Amendment1y ago
Company AnnouncementsNéovacs Raises €0.25 Million for Allergy Research Amid Dilution Concerns1y ago
Company AnnouncementsNéovacs Reports Share Capital Structure Amid Dilutive Financing Concerns1y ago
Company AnnouncementsNéovacs Seeks Partners for mRNA Asthma Program Valued at €98 Million1y ago
Company AnnouncementsNeovacs Embraces mRNA and Strategic Partnerships2y ago
Company AnnouncementsNeovacs SA Cautiously Manages Pharnext Investment2y ago- Company AnnouncementsNeovacs SA Announces New Fundraising Effort2y ago
- Company AnnouncementsNeovacs SA Shares and Voting Rights Update2y ago
- Company AnnouncementsNeovacs SA Collaborates on Asthma mRNA Vaccine2y ago
Company AnnouncementsNeovacs SA Announces Capital Reduction2y ago
Company AnnouncementsNeovacs SA Ends Contract with Pharnext Amid Defaults2y ago- Company AnnouncementsNeovacs SA Declines Further Support to Pharnext2y ago
Company AnnouncementsNeovacs SA Board Declines Further Pharnext Support2y ago
Company AnnouncementsNeovacs Partners with CNRS for mRNA Vaccine Development2y ago
Company AnnouncementsNeovacs SA Schedules Second Shareholder Meeting2y ago